| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Satvik Mareedu, Emily D Million, Dongsheng Duan, Gopal J Bab. Abnormal Calcium Handling in Duchenne Muscular Dystrophy: Mechanisms and Potential Therapies. Frontiers in physiology. vol 12. 2021-10-16. PMID:33897454. |
dmd is associated with muscle degeneration, necrosis, inflammation, fatty replacement, and fibrosis, resulting in muscle weakness, respiratory and cardiac failure, and premature death. |
2021-10-16 |
2023-08-13 |
Not clear |
| Pangdra Vang, Cory W Baumann, Rebecca Barok, Alexie A Larson, Brendan J Dougherty, Dawn A Low. Impact of estrogen deficiency on diaphragm and leg muscle contractile function in female mdx mice. PloS one. vol 16. issue 3. 2021-10-15. PMID:33788896. |
female carriers of duchenne muscular dystrophy (dmd) presenting with dmd symptomology similar to males with dmd, such as skeletal muscle weakness and cardiomyopathy, are termed manifesting carriers. |
2021-10-15 |
2023-08-13 |
mouse |
| Alison M Barnard, Donovan J Lott, Abhinandan Batra, William T Triplett, Rebecca J Willcocks, Sean C Forbes, William D Rooney, Michael J Daniels, Barbara K Smith, Krista Vandenborne, Glenn A Walte. Characterizing Expiratory Respiratory Muscle Degeneration in Duchenne Muscular Dystrophy Using MRI. Chest. 2021-10-10. PMID:34536384. |
expiratory muscle weakness and impaired airway clearance are early signs of respiratory dysfunction in duchenne muscular dystrophy (dmd), a degenerative muscle disorder in which muscle cells are damaged and replaced by fibrofatty tissue. |
2021-10-10 |
2023-08-13 |
Not clear |
| Oscar Yuan-Jie Shen, Yi-Fan Chen, Hong-Tao Xu, Chien-Wei Le. The Efficacy of Naïve versus Modified Mesenchymal Stem Cells in Improving Muscle Function in Duchenne Muscular Dystrophy: A Systematic Review. Biomedicines. vol 9. issue 9. 2021-10-01. PMID:34572283. |
as one of the most common genetic conditions, duchenne muscular dystrophy (dmd) is a fatal disease caused by a recessive mutation resulting in muscle weakness in both voluntary and involuntary muscles and, eventually, in death because of cardiovascular failure. |
2021-10-01 |
2023-08-13 |
mouse |
| Sai Yarlagadda, Christina Kulis, Peter G Noakes, Mark L Smyth. Hematopoietic Prostaglandin D Synthase Inhibitor PK007 Decreases Muscle Necrosis in DMD Life (Basel, Switzerland). vol 11. issue 9. 2021-10-01. PMID:34575143. |
hematopoietic prostaglandin d synthase inhibitor pk007 decreases muscle necrosis in dmd duchenne muscular dystrophy (dmd) is characterized by progressive muscle weakness and wasting due to the lack of dystrophin protein. |
2021-10-01 |
2023-08-13 |
Not clear |
| Zoe E Davidson, Ian Hughes, Monique M Ryan, Andrew J Kornberg, Anita G Cairns, Kristi Jones, Meghan Hutchence, Hugo Sampaio, Margot Morrison, Helen Trub. Effect of a multicomponent nutritional supplement on functional outcomes for Duchenne muscular dystrophy: A randomized controlled trial. Clinical nutrition (Edinburgh, Scotland). vol 40. issue 7. 2021-09-14. PMID:34237697. |
duchenne muscular dystrophy (dmd) is an x-linked neuromuscular condition causing progressive muscle weakness and premature death. |
2021-09-14 |
2023-08-13 |
Not clear |
| Yuri Fujikura, Hidetoshi Sugihara, Masaki Hatakeyama, Katsutaka Oishi, Keitaro Yamanouch. Ketogenic diet with medium-chain triglycerides restores skeletal muscle function and pathology in a rat model of Duchenne muscular dystrophy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 35. issue 9. 2021-09-09. PMID:34416029. |
duchenne muscular dystrophy (dmd) is an intractable genetic disease associated with progressive skeletal muscle weakness and degeneration. |
2021-09-09 |
2023-08-13 |
rat |
| Cuixia Tian, Brenda L Wong, Lindsey Hornung, Jane C Khoury, Irina Rybalsky, Karen C Shellenbarger, Meilan M Rutte. Oral bisphosphonate treatment in patients with Duchenne muscular dystrophy on long term glucocorticoid therapy. Neuromuscular disorders : NMD. vol 30. issue 7. 2021-08-11. PMID:32680651. |
osteoporosis is a major problem in patients with duchenne muscular dystrophy (dmd), due to glucocorticoid therapy and muscle weakness. |
2021-08-11 |
2023-08-13 |
Not clear |
| Mary Killian, Maciej S Buchowski, Thomas Donnelly, W Bryan Burnette, Larry W Markham, James C Slaughter, Meng Xu, Kimberly Crum, Bruce M Damon, Jonathan H Soslo. Beyond ambulation: Measuring physical activity in youth with Duchenne muscular dystrophy. Neuromuscular disorders : NMD. vol 30. issue 4. 2021-07-26. PMID:32291149. |
patients with duchenne muscular dystrophy (dmd) develop skeletal muscle weakness and cardiomyopathy. |
2021-07-26 |
2023-08-13 |
human |
| Omar Sheikh, Toshifumi Yokot. Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. vol 35. issue 4. 2021-07-23. PMID:34097287. |
while dmd causes generalized muscle weakness due to the absence of the dystrophin protein, sma patients generally face motor neuron degeneration because of the lack of the survival motor neuron (smn) protein. |
2021-07-23 |
2023-08-13 |
Not clear |
| Abhinandan Batra, Donovan J Lott, Rebecca Willcocks, Sean C Forbes, William Triplett, Jahannaz Dastgir, Pomi Yun, A Reghan Foley, Carsten G Bönnemann, Krista Vandenborne, Glenn A Walte. Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study. Journal of neuromuscular diseases. vol 7. issue 4. 2021-07-22. PMID:32538860. |
collagen vi-related dystrophies (col6-rds) and duchenne muscular dystrophy (dmd) cause progressive muscle weakness and disability. |
2021-07-22 |
2023-08-13 |
Not clear |
| Letizia Brogi, Maria Marchese, Alessandro Cellerino, Rosario Licitra, Valentina Naef, Serena Mero, Carlo Bibbiani, Baldassare Front. β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy. Nutrients. vol 13. issue 5. 2021-07-21. PMID:34065946. |
duchenne muscular dystrophy (dmd) is a severe x-linked neuromuscular childhood disorder that causes progressive muscle weakness and degeneration. |
2021-07-21 |
2023-08-13 |
Not clear |
| Christopher Lopez, Tanja Taivassalo, Maria G Berru, Andres Saavedra, Hannah C Rasmussen, Abhinandan Batra, Harneet Arora, Alex M Roetzheim, Glenn A Walter, Krista Vandenborne, Sean C Forbe. Postcontractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy. Journal of applied physiology (Bethesda, Md. : 1985). vol 131. issue 1. 2021-07-14. PMID:34013753. |
duchenne muscular dystrophy (dmd) is characterized by a progressive replacement of muscle by fat and fibrous tissue, muscle weakness, and loss of functional abilities. |
2021-07-14 |
2023-08-13 |
Not clear |
| Urszula Florczyk-Soluch, Katarzyna Polak, Józef Dula. The multifaceted view of heart problem in Duchenne muscular dystrophy. Cellular and molecular life sciences : CMLS. vol 78. issue 14. 2021-07-09. PMID:34091693. |
although clinically dmd manifests as progressive muscle weakness and skeletal muscle symptoms define characteristic of dmd, it is the heart problem the biggest challenge that most often develop in the form of dilated cardiomyopathy (dcm). |
2021-07-09 |
2023-08-13 |
Not clear |
| Douglas W Van Pelt, Yalda A Kharaz, Dylan C Sarver, Logan R Eckhardt, Justin T Dzierzawski, Nathaniel P Disser, Alex N Piacentini, Eithne Comerford, Brian McDonagh, Christopher L Mendia. Multiomics analysis of the mdx/mTR mouse model of Duchenne muscular dystrophy. Connective tissue research. vol 62. issue 1. 2021-07-08. PMID:32664808. |
duchenne muscular dystrophy (dmd) is a progressive neuromuscular disease characterized by extensive muscle weakness. |
2021-07-08 |
2023-08-13 |
mouse |
| Hye-Jin Kim, Soo-Yeon Kim, Min Ho Ju, Soo Yong Lee, Gyeong-Jo Byeon, Hee Young Ki. Early extubation after left ventricular assist device implantation in a patient with Duchenne muscular dystrophy: a case report. Journal of anesthesia. vol 35. issue 3. 2021-07-08. PMID:33782774. |
respiratory failure may occur due to muscle weakness after surgery under general anesthesia in patients with dmd, and weaning from mechanical ventilation may be delayed or difficult. |
2021-07-08 |
2023-08-13 |
Not clear |
| Agnieszka Łoboda, Józef Dula. Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future. Pharmacological reports : PR. vol 72. issue 5. 2021-07-02. PMID:32691346. |
duchenne muscular dystrophy (dmd) is a severe x-linked neuromuscular childhood disorder that causes progressive muscle weakness and degeneration and results in functional decline, loss of ambulation and early death of young men due to cardiac or respiratory failure. |
2021-07-02 |
2023-08-13 |
human |
| Meral Bilgilisoy Filiz, Naciye Füsun Toraman, Muhammet Gültekin Kutluk, Serkan Filiz, Şebnem Koldaş Doğan, Tuncay Çakır, Aylin Yama. Effects of lumbar lordosis increment on gait deteriorations in ambulant boys with Duchenne Muscular Dystrophy: A cross-sectional study. Brazilian journal of physical therapy. 2021-06-13. PMID:34119442. |
increment of lumbar lordosis, a frequent spinal finding in duchenne muscular dystrophy (dmd), is a compensatory mechanism secondary to muscle weakness. |
2021-06-13 |
2023-08-13 |
Not clear |
| Xia Dong, Tiankun Hui, Jie Chen, Zheng Yu, Dongyan Ren, Suqi Zou, Shunqi Wang, Erkang Fei, Huifeng Jiao, Xinsheng La. Metformin Frontiers in physiology. vol 12. 2021-05-22. PMID:34012406. |
metformin duchenne muscular dystrophy (dmd) is a genetic neuromuscular disease characterized by progressive muscle weakness and wasting. |
2021-05-22 |
2023-08-13 |
mouse |
| Ryouhei Komaki, Yasumasa Hashimoto, Madoka Mori-Yoshimura, Yasushi Oya, Hotake Takizawa, Narihiro Minami, Ichizo Nishino, Yoshitsugu Aoki, Yuji Takahash. Severe cardiac involvement with preserved truncated dystrophin expression in Becker muscular dystrophy by +1G>A DMD splice-site mutation: a case report. Journal of human genetics. vol 65. issue 10. 2021-05-06. PMID:32504006. |
becker muscular dystrophy (bmd) is caused by specific mutations in the dmd gene that causes progressive muscle weakness and primarily affects skeletal and cardiac muscle. |
2021-05-06 |
2023-08-13 |
Not clear |